Search

Displaying results 7061 - 7070 of 8517 in total
  1. Drug

    Mezigdomide

    go.drugbank.com/drugs/DB17584
    Investigational

    Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants

  2. Drug

    RGX-111

    go.drugbank.com/drugs/DB17632
    Investigational

    Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]

  3. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    Ambasilide has a monoisotopic molecular weight of 335.2 Da.

  4. Drug

    Isoquercetin

    go.drugbank.com/drugs/DB12665
    Investigational

    Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein

  5. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    Bitipazone has a monoisotopic molecular weight of 454.27 Da.

  6. Drug

    IR501

    go.drugbank.com/drugs/DB06464
    Experimental

    It was last known to be in phase III clinical trials.

  7. Drug

    Benhepazone

    go.drugbank.com/drugs/DB20980
    Experimental

    Benhepazone has a monoisotopic molecular weight of 236.09 Da.

  8. Drug

    Tianafac

    go.drugbank.com/drugs/DB21045
    Experimental

    Tianafac has a monoisotopic molecular weight of 240.0 Da.

  9. Drug

    Ciproquazone

    go.drugbank.com/drugs/DB21064
    Experimental

    Ciproquazone has a monoisotopic molecular weight of 306.14 Da.

  10. Drug

    Feclobuzone

    go.drugbank.com/drugs/DB21131
    Experimental

    Feclobuzone has a monoisotopic molecular weight of 476.15 Da.